Diabetes is a common disease associated with high levels of glucose in the body due
to poor insulin function or secretion, and it has significant health implications
worldwide. Diabetes can be managed through the use of drugs, insulin, and dietary
modifications to achieve normoglycemia. D-Allulose is a low-calorie sugar
substitute that is showing promise. The current research work discusses the
characteristics, metabolism, and effects of D-Allulose on the metabolism of sugars.
D-Allulose possesses an impressive ability to induce hypoglycemic action. It has
been proven to lower postprandial glucose in patients with diabetes and improve
glycemic state for long periods. Moreover, D-Allulose may potentially reduce tissue
insulin resistance and decrease the progression of diabetic nephropathy. The ways
D-Allulose affects the body are associated with competition of D-Allulose and
glucose for their intestinal transporters, inhibition of intestinal enzymes and
hormones activation. From a safety standpoint, D-Allulose does not demonstrate
adverse events. Despite current technological problems in the production process,
further development of bacterial epimerase technology suggests that large-scale
production of D-Allulose can become possible in the near future.
Keywords: diabetes mellitus, d-allulose, glycemia, dpsicode
